Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis (Q43591): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Revision as of 10:40, 13 August 2026
This is an acute hepatocellular injury that develops within 1 to 20 weeks after starting treatment. The histological lesions consist mainly of focal, zonal or bridging necrosis, but lobular and portal tract inflammation evident with drug hepatitis. Extrahepatic features of drug hypersensitivity, including rash, lymphadenopathy, eosinophilia or other systemic features, are observed in some cases.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | DB95.0 |
||
| English | Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis |
This is an acute hepatocellular injury that develops within 1 to 20 weeks after starting treatment. The histological lesions consist mainly of focal, zonal or bridging necrosis, but lobular and portal tract inflammation evident with drug hepatitis. Extrahepatic features of drug hypersensitivity, including rash, lymphadenopathy, eosinophilia or other systemic features, are observed in some cases. |
Statements
CID11:DB95.0
0 references
dki-india-DB95.0
0 references
Concluído
0 references
13 August 2026
0 references
